These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 21910787)
21. Abnormalities in peripheral B cell memory of patients with primary Sjögren's syndrome. Hansen A; Gosemann M; Pruss A; Reiter K; Ruzickova S; Lipsky PE; Dörner T Arthritis Rheum; 2004 Jun; 50(6):1897-908. PubMed ID: 15188366 [TBL] [Abstract][Full Text] [Related]
22. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy. Kubisz P; Plamenová I; Hollý P; Stasko J Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019 [TBL] [Abstract][Full Text] [Related]
23. Cytokine production by CD4+ T cells specific for coagulation factor VIII in healthy subjects and haemophilia A patients. Hu G; Guo D; Key NS; Conti-Fine BM Thromb Haemost; 2007 May; 97(5):788-94. PubMed ID: 17479189 [TBL] [Abstract][Full Text] [Related]
24. CD8+HLA-DR+ T lymphocytes are increased in common variable immunodeficiency patients with impaired memory B-cell differentiation. Viallard JF; Blanco P; André M; Etienne G; Liferman F; Neau D; Vidal E; Moreau JF; Pellegrin JL Clin Immunol; 2006 Apr; 119(1):51-8. PubMed ID: 16413828 [TBL] [Abstract][Full Text] [Related]
25. Circulating FVIII-specific IgG, IgA and IgM memory B cells from haemophilia A patients. Diaz I; Bolloré K; Tuaillon E; Lapalud P; Giansily-Blaizot M; Vendrell JP; Schved JF; Lavigne-Lissalde G Haemophilia; 2016 Sep; 22(5):799-805. PubMed ID: 27439547 [TBL] [Abstract][Full Text] [Related]
26. Early factor VIII exposure and subsequent inhibitor development in children with severe haemophilia A. Chalmers EA; Brown SA; Keeling D; Liesner R; Richards M; Stirling D; Thomas A; Vidler V; Williams MD; Young D; Haemophilia; 2007 Mar; 13(2):149-55. PubMed ID: 17286767 [TBL] [Abstract][Full Text] [Related]
27. Immune response against serial infusion of factor VIII antigen through an implantable venous-access device system in haemophilia A mice. Madoiwa S; Kobayashi E; Kashiwakura Y; Sakata A; Yasumoto A; Ohmori T; Mimuro J; Sakata Y Haemophilia; 2012 May; 18(3):e323-30. PubMed ID: 22044430 [TBL] [Abstract][Full Text] [Related]
28. B Cell Depletion Eliminates FVIII Memory B Cells and Enhances AAV8-coF8 Immune Tolerance Induction When Combined With Rapamycin. Biswas M; Palaschak B; Kumar SRP; Rana J; Markusic DM Front Immunol; 2020; 11():1293. PubMed ID: 32670285 [TBL] [Abstract][Full Text] [Related]
29. Role of anti-idiotypic antibodies in immune tolerance induction. Gilles JG Haemophilia; 2010 May; 16(102):80-3. PubMed ID: 20536989 [TBL] [Abstract][Full Text] [Related]
30. Late immune tolerance induction in haemophilia A patients. Meeks SL; Chapman RL; Kempton C; Dunn AL Haemophilia; 2013 May; 19(3):445-8. PubMed ID: 23294063 [TBL] [Abstract][Full Text] [Related]
31. Low prevalence of inhibitor antibodies in the Canadian haemophilia population. Webert KE; Rivard GE; Teitel J; Carcao M; Lillicrap D; St-Louis J; Walker IR Haemophilia; 2012 May; 18(3):e254-9. PubMed ID: 22077390 [TBL] [Abstract][Full Text] [Related]
32. Single cell analysis of factor VIII-specific T cells in hemophilic mice after treatment with human factor VIII. Sasgary M; Ahmad RU; Schwarz HP; Turecek PL; Reipert BM Thromb Haemost; 2002 Feb; 87(2):266-72. PubMed ID: 11858486 [TBL] [Abstract][Full Text] [Related]
33. Association of anti-idiotypic antibodies with immune tolerance induction for the treatment of hemophilia A with inhibitors. Sakurai Y; Shima M; Tanaka I; Fukuda K; Yoshida K; Yoshioka A Haematologica; 2004 Jun; 89(6):696-703. PubMed ID: 15194537 [TBL] [Abstract][Full Text] [Related]
34. Deletion or inhibition of Fc gamma receptor 2B (CD32) prevents FVIII-specific activation of memory B cells in vitro. Werwitzke S; Vollack N; von Hornung M; Kalippke K; Kutzschbach J; Trummer A; Ganser A; Tiede A Thromb Haemost; 2015 Nov; 114(6):1127-35. PubMed ID: 26245154 [TBL] [Abstract][Full Text] [Related]
36. Analysis of switched memory B cells in patients with IgA deficiency. Aghamohammadi A; Abolhassani H; Biglari M; Abolmaali S; Moazzami K; Tabatabaeiyan M; Asgarian-Omran H; Parvaneh N; Mirahmadian M; Rezaei N Int Arch Allergy Immunol; 2011; 156(4):462-8. PubMed ID: 21832837 [TBL] [Abstract][Full Text] [Related]
37. Memory B-cells in healthy and antibody-deficient children. Huck K; Feyen O; Ghosh S; Beltz K; Bellert S; Niehues T Clin Immunol; 2009 Apr; 131(1):50-9. PubMed ID: 19162556 [TBL] [Abstract][Full Text] [Related]
38. B cell subpopulations separated by CD27 and crucial collaboration of CD27+ B cells and helper T cells in immunoglobulin production. Agematsu K; Nagumo H; Yang FC; Nakazawa T; Fukushima K; Ito S; Sugita K; Mori T; Kobata T; Morimoto C; Komiyama A Eur J Immunol; 1997 Aug; 27(8):2073-9. PubMed ID: 9295047 [TBL] [Abstract][Full Text] [Related]
39. The role of VWF for the success of immune tolerance induction. Kreuz W Thromb Res; 2008; 122 Suppl 2():S7-S12. PubMed ID: 18549910 [TBL] [Abstract][Full Text] [Related]
40. Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype. Jarvis MA; Levin LG; Harrison JA; DePianto DJ; Suzuki CM; Ziaja CL; Brown JE; Jolly KW; Reisner HM; Abildgaard CF; Powell JS Thromb Haemost; 1996 Feb; 75(2):318-25. PubMed ID: 8815584 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]